Group 1 - The company held its 13th meeting of the third Supervisory Board on June 13, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The Supervisory Board approved the proposal to conclude certain fundraising projects and permanently supplement the remaining funds into working capital, which is deemed reasonable and beneficial for the company's development [1] - The proposal received unanimous approval with 3 votes in favor, and it will be submitted to the shareholders' meeting for further review [2][3] Group 2 - The company also approved a proposal to amend its Articles of Association and related documents to align with the latest laws and regulations, enhancing corporate governance [2] - The amendments include revisions to certain provisions of the current Articles of Association and the corresponding rules, with the Supervisory Board's rules being abolished [2] - This proposal also received unanimous approval with 3 votes in favor and will be submitted to the shareholders' meeting for further review [3]

Group 1 - The company held its 13th meeting of the 5th Supervisory Board on June 11, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal to abolish the Supervisory Board and transfer its powers to the Audit Committee of the Board of Directors, along with the corresponding repeal of the rules governing the Supervisory Board [1][2] - The Supervisory Board agreed to adjust the company's business scope in accordance with the requirements of the State Administration for Market Regulation [2]

Group 1 - The company held its eighth meeting of the third supervisory board on June 6, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The supervisory board approved a proposal to change the registered capital and amend the company's articles of association, in accordance with the latest legal requirements [1] - The company plans to distribute a cash dividend of 1.50 yuan per share, totaling 12,368,453.40 yuan, while retaining the remaining undistributed profits for the next fiscal year [2] Group 2 - The proposal for capital increase through capital reserves involves a transfer of shares to all shareholders at a ratio of 1 for every 10 shares held, with no bonus shares being issued [2] - The voting results for the proposal showed unanimous support, with 3 votes in favor and no votes against or abstentions [2] - The proposal will be submitted for review at the company's third extraordinary general meeting in 2025 [2]

证券代码：688265 证券简称：南模生物 公告编号：2025-033 上海南方模式生物科技股份有限公司 第三届董事会第二十一次会议 决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 有董事对本次董事会第10项议案、第15项议案投反对票、弃权票。 ● 本次董事会第10项议案、第15项议案未获通过。 一、董事会会议召开情况 上海南方模式生物科技股份有限公司（以下简称"公司" 或"南模生物"）第三届董事会第二十一次会议 于2025年5月29日以现场结合通讯方式召开。本次会议的通知已于2025年5月26日以电子邮件方式送达全 体董事。本次会议由董事长费俭先生召集并主持，应参会董事9人，实际出席董事9人，其中独立董事3 人，公司监事、高级管理人员列席了会议。本次会议的召集、召开符合《中华人民共和国公司法》等法 律法规及《公司章程》的相关规定。 二、董事会会议审议情况 1、审议通过《关于调整董事会席位的议案》 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）披露的《关于调整董事会 ...

Group 1 - The board of directors of Hisense Home Appliances Group Co., Ltd. held its third interim meeting of the 2025 fiscal year on May 27, 2025, with all nine directors present [1] - The board approved the unlocking of shares under the 2022 A-share employee stock ownership plan, with a total of 3,386,630 shares eligible for unlocking, representing 0.25% of the company's total share capital [2][3] - The board also approved the unlocking of 6,397,866 shares under the 2022 A-share restricted stock incentive plan, which accounts for 0.46% of the company's total share capital [3] Group 2 - The first unlocking period of the 2024 A-share employee stock ownership plan is set to expire on July 15, 2025, with 4,419,638 shares eligible for unlocking, representing 0.32% of the company's total share capital [4] - The board approved a proposal to repurchase and cancel 755,634 shares of restricted stock due to various reasons including employee departures and performance evaluations [5] - The board proposed amendments to the company's articles of association and related rules, including the abolition of the supervisory board, which will be replaced by the audit committee of the board [6] Group 3 - The board proposed to grant general authority to issue A-shares or H-shares, not exceeding 20% of the total issued shares, subject to shareholder approval [7][8] - The board also sought authorization to issue debt financing instruments, including various types of bonds, with a maximum term of 15 years [9][10] - The company plans to provide guarantees for its subsidiaries, with a total guarantee limit of up to RMB 8 billion for 2026 [14][15] Group 4 - The board approved the basic annual salary for the chairman at RMB 1.596 million before tax, which will be submitted for shareholder approval [13] - The board approved the appointment of a securities affairs representative, which will also be disclosed to shareholders [13] - The board proposed to hold the 2024 annual general meeting of shareholders, with all resolutions receiving unanimous support [15]

证券代码：002229 证券简称：鸿博股份 公告编号：2025-028 鸿博股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 鸿博股份有限公司（以下简称"公司"）第六届监事会第二十七次会议于 2025 年 及通讯的方式召开。会议通知已于 2025 年 5 月 22 日以专人送达、传真、电子邮件 等方式送达全体监事及高级管理人员。本次会议应到监事 3 名，实到监事 3 名。会 议的召集、召开符合《中华人民共和国公司法》和《公司章程》的有关规定。 一、以 3 票赞成、0 票反对、0 票弃权的表决结果审议通过《关于回购注销激励 对象部分已获授但尚未解除限售的限制性股票的议案》。 《关于回购注销激励对象部分已获授但尚未解除限售的限制性股票的公告》 （公 告编号：2025-029）的具体内容详见《证券时报》、《上海证券报》和巨潮资讯网 （www.cninfo.com.cn）。 公司拟减少注册资本并同时修改公司章程的相关内容，同时提请公司股东会授 权公司管理层办理相关工商变更登记备案等手续。 本次会议由监事会主席胡伟先生召集并主持，与会监事就各项议案进行了审议 ...

Core Viewpoint - Sichuan Porton Medical Equipment Group Co., Ltd. is undergoing a board restructuring process, with nominations for both non-independent and independent directors for the fifth board, aiming to promote the company's stable and healthy development [1][2][3]. Board Restructuring - The fourth board's term will end on June 11, 2025, prompting the need for a new election [1][2]. - The board has nominated five candidates for non-independent directors: Chen Yong, Chen Xinggen, Wen Zaimin, Chen Xu, and Liu Yuqiang, with a term of three years starting from the shareholders' meeting approval [1][2]. - The board has also nominated three candidates for independent directors: Zhou Zheng, Zhao Chen, and Yao Gang, with the same term conditions [1][3]. Voting Results - All nominations for both non-independent and independent directors received unanimous approval, with 9 votes in favor and no opposition or abstentions [2][3]. Amendments to Company Regulations - The board approved amendments to the company's articles of association, including the abolition of the supervisory meeting rules, to enhance corporate governance and internal control [4]. - The board also agreed to revise several internal regulations, including the shareholder meeting rules and fundraising management system, to align with current laws and regulations [5]. Upcoming Shareholder Meeting - The board proposed to convene the 2024 annual shareholders' meeting to discuss the approved nominations and amendments [5].

Core Viewpoint - The company is undergoing a board restructuring, with nominations for both non-independent and independent directors for the sixth board, which will serve a three-year term starting from the approval date at the first extraordinary shareholders' meeting in 2025 [1][2][3]. Group 1: Board Restructuring - The fifth board's term will expire on May 15, 2025, prompting the nomination of candidates for the sixth board [1][2]. - Non-independent director candidates include Chen Xiao, Yan Xuewen, Wei Shaohua, Chen Linchi, and Fan Gaihuan, all of whom received unanimous approval from the board [2][3]. - Independent director candidates include Yang Ying, Wang Zongzheng, and Zhu Jun, also receiving unanimous approval [3][4]. Group 2: Compensation and Capital Changes - The proposed annual compensation for independent directors is set at RMB 80,000 (pre-tax), to be paid monthly [4]. - The company plans to change its registered capital from RMB 437,135,321 to RMB 437,282,217 due to the conversion of "Hongfeng Convertible Bonds" that began on September 21, 2022 [4][5]. Group 3: Governance Structure Adjustments - The company intends to adjust its governance structure by transferring the supervisory board's powers to the audit committee of the board, necessitating amendments to the company’s articles of association [5][6]. - The company will revise its governance rules, including the rules for shareholders' meetings and board meetings, in line with the new structure [6]. Group 4: Shareholders' Meeting - The company plans to convene the first extraordinary shareholders' meeting on May 26, 2025, to vote on the proposed changes and nominations [6][7].

2024年年度股东会增加临时提案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 证券代码：605123 证券简称：派克新材 公告编号：2025-021 无锡派克新材料科技股份有限公司关于 1.股东会的类型和届次： 2024年年度股东会 2.股东会召开日期：2025年5月19日 3.股权登记日 一、股东会有关情况 ■ 二、增加临时提案的情况说明 1.提案人：是玉丰 2.提案程序说明 公司已于2025年4月29日公告了股东会召开通知，单独或者合计持有20.18%股份的股东是玉丰，在2025 年5月7日提出临时提案并书面提交股东会召集人。股东会召集人按照《上市公司股东大会规则》有关规 定，现予以公告。 三、除了上述增加临时提案外，于2025年4月29日公告的原股东会通知事项不变。 四、增加临时提案后股东会的有关情况。 (一)现场会议召开的日期、时间和地点 召开日期时间：2025年5月19日 10点 00分 召开地点：公司会议室 (二)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络 ...